Skip to main content
In stock|Bone-Modifying Agent

Risedronate (Onc Adjacent)

Oncology TypeBoth (Solid & Hematologic)
Drug Class / MechanismBisphosphonate
No Image
Description

Risedronate (Onc Adjacent) is classified as a Bisphosphonate, sourced for use within our Bone-Modifying Agent portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryBone-Modifying Agent
Oncology TypeBoth (Solid & Hematologic)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3